Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Human Alpha1-Proteinase Inhibitor (respiratory use)

EU orphan designation number: EU/3/01/044   
Active ingredient: Human Alpha1-Proteinase Inhibitor (respiratory use)
Indication: Treatment of emphysema secondary to congenital alpha 1-antitrypsin deficiency
Sponsor: CSL Behring GmbH
Emil-von-Behring-Straße 76, 35041 Marburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/07/2001 Orphan designation EMEA/OD/045/00 (2001)1397 of 9/07/2001
7/02/2005 Change of name and/or address of sponsor
13/04/2007 Change of name and/or address of sponsor